19 June 2013
Keywords: serono, ivax, initiate, ph, iii, ms, trial
Article | 24 January 2005
Under an agreement signed in 2002, Swiss biotechnology group Serono and the USA's IVAX have unveiled plans to start a Phase ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 January 2005
© 2013 thepharmaletter.com